M&A Drives 2024 Medtech Big 100 Growth in Sales, R&D Spending and Total Employment
Thursday, 29 August 2024, 14:12
M&A Drives Growth in Medtech
As mergers and acquisitions dominate the medtech landscape, the Big 100 companies are recording substantial growth in sales, research, and development (R&D) spending. This trend signifies a strong trajectory for the industry, with many firms strategically increasing resources to strengthen their market position.
Impact of M&A on Sales and Employment
- Sales Growth: The Big 100 have reported robust sales gains, driven by strategic acquisitions.
- R&D Investment: Increased spending in R&D highlights innovation as a priority for these firms.
- Total Employment: While some layoffs occurred, overall employment numbers have risen due to the M&A activities.
Overall, M&A is catalyzing growth in sales and R&D, driven by a focus on innovation and market expansion.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.